Filtered By:
Drug: Rituxan
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 5018 results found since Jan 2013.
Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays
In conclusion, anti-Dsg1, anti-Dsg3, and IIF autoantibody titers remain standard biomarkers for assessing disease activity, severity, and PV monitoring. The trend of CRP was similar to that of anti-Dsg1, anti-Dsg3, and IIF. Thus, CRP may be used for PV monitoring.PMID:37524667 | DOI:10.18502/ijaai.v22i3.13059
Source: Iranian Journal of Allergy, Asthma and Immunology - July 31, 2023 Category: Allergy & Immunology Authors: Hossein Mortazavi Vahide Saeidi Kamran Balighi Nafiseh Esmaeili Amir Teimourpour Maryam Daneshpazhooh Shahin Hamzelou Zahra Saffarian Jafar Taghizadeh Fazli Source Type: research
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee
Int J Hematol. 2023 Jul 29. doi: 10.1007/s12185-023-03647-2. Online ahead of print.ABSTRACTWe retrospectively gathered data of 21 patients (13 male and 8 female; median age 65 years) diagnosed with immunoglobulin M (IgM)-related light-chain (AL) amyloidosis in Japan to investigate characteristics of IgM-AL amyloidosis and its optimal treatment strategy. Median IgM and difference free light chain (FLC) at diagnosis were 1257 mg/dl and 34.3 mg/l, respectively. Organ involvement was observed in the heart in 7 patients (33%), kidneys in 15 (71%), and lymph nodes in 5 (24%). Initial treatments were melphalan/dexamethasone in 7 ...
Source: International Journal of Hematology - July 29, 2023 Category: Hematology Authors: Shin-Ichi Fuchida Mizuki Ogura Tadao Ishida Hiroyuki Hata Hiroshi Handa Nagaaki Katoh Chiaki Nakaseko Kazutaka Sunami Yuta Katayama Hironobu Nobata Kazuiku Oshiro Shinsuke Iida Yoshiki Sekijima Hironobu Naiki Chihiro Shimazaki Source Type: research
Rituximab-associated PRES in antibody-mediated kidney rejection: A case report
Transpl Immunol. 2023 Jul 26;80:101907. doi: 10.1016/j.trim.2023.101907. Online ahead of print.ABSTRACTPosterior Reversible Encephalopathy Syndrome (PRES) is a rare neurological disorder with a wide range of neurological symptoms. Different risk factors are known for PRES in patients with a history of kidney transplantation; these patients developing PRES were associated with immunosuppressants and cytotoxic drug therapies, including reports of rituximab therapy. Herein, we report a case of rituximab-associated PRES in the context of antibody-mediated kidney allograft rejection. A 29-year-old male patient with antibody-med...
Source: Transplant Immunology - July 28, 2023 Category: Transplant Surgery Authors: Masoud Etemadifar Seyyed-Ali Alaei Elahe Saffari Mehri Salari Source Type: research
Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient data
CONCLUSION: AQP4+NMOSD in SLE patients is a relapsing and neurologically disabling disorder that can mimic neuropsychiatric manifestations, frequently occurs after the onset of lupus or may predate, responds to immunosuppressants, and necessitates indefinite treatment.PMID:37487596 | DOI:10.1177/09612033231191180
Source: Lupus - July 24, 2023 Category: Rheumatology Authors: Chirag Rajkumar Kopp Chandra Bhushan Prasad Shankar Naidu Vishal Sharma Durga Prasanna Misra Vikas Agarwal Aman Sharma Source Type: research
